1. Pharmacological and Host Considerations Surrounding Dose Selection and Duration of Therapy with Echinocandins

   • Chin Fen Neoh
   • David C. M. Kong
   • Sharon C.-A. Chen

   Pharmacology and Pharmacodynamics of Antifungal Agents (ME Klepser, Section Editor) 23 March 2012 Pages: 95 - 106

2. Clinical Relevance of In Vitro Resistance of Echinocandins: a Focus on Candida parapsilosis

   • Pramodini B. Kale-Pradhan
   • Sheila M. Wilhelm
   • Leonard B. Johnson

   Pharmacology and Pharmacodynamics of Antifungal Agents (ME Klepser, Section Editor) 13 April 2012 Pages: 107 - 112

3. Coccidioidomycosis: An Update

   • Rafael Laniado-Laborin
   • Juan Manuel Alcantar-Schramm
   • Rebeca Cazares-Adame

   Pharmacology and Pharacodynamics of Antifungal Agents (ME Klepser, Section Editor) 28 March 2012 Pages: 113 - 120

   

4. Pharmacokinetics, Safety and Efficacy of Voriconazole in Pediatric Patients: An Update

   • Charalampos Dokos
   • Stephanie Pieper
   • Andreas H. Groll

   Pharmacology and Pharmacodynamics of Antifungal Agents (ME Klepser, Section Editor) 28 April 2012 Pages: 121 - 126

   

5. Pharmacological and Host Considerations in the Selection of Dose and Duration of Azole Therapy for Adult Patients

   • Michael E. Klepser

   Pharmacology and Pharmacodynamics of Antifungal Agents (ME Klepser, Section Editor) 28 April 2012 Pages: 127 - 132

6. Report from the 5th Trends in Medical Mycology, Valencia, Spain, 2–5 October 2011

   • Manuel Cuenca-Estrella
   • Jenny Bryan

   Hot Topic 03 April 2012 Pages: 133 - 137

7. International Pediatric Fungal Network: Changing the World for Pediatric Invasive Fungal Infections

   • William J. Steinbach

   Invited Commentary 20 April 2012 Pages: 138 - 139